Encision, Inc. Reports Third Quarter Fiscal Year 2017 Results; Sequential Quarterly Revenue Grows 4 Percent Post author:Sam Post published:February 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Disease… December 4, 2017 <b>EBS Technologies</b> Appoints <b>Karl Schweitzer</b> As Chief Executive Officer August 27, 2017 Massachusetts Biotech Startup Launches With $23.5 Million June 20, 2017
Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Disease… December 4, 2017